Moreover, we examined the effect of anti-FGF9 neutralizing antibody on gastric cancer cells and found that the increased expression of p-Akt and p-ERK elicited by FGF9 stimulation was attenuated by concomitant administration of anti-FGF9 neutralizing antibody (Figure 2C). This evidence concerns the gene FGF9 and gastric cancer.